Drooid Logo
Back to today’s briefing

Story perspectives

Study Reveals Ketamine Infusions Offer No Extra Benefits

10/23/2025

36 5

1 of 1

Story summary
  • A study published in JAMA Psychiatry found repeated ketamine infusions do not add benefits over standard inpatient care for major depression.
  • The trial involved 65 participants and compared ketamine to midazolam, with no significant differences in depression, cognition, or quality of life.
  • Researchers noted many participants correctly guessed their treatment, which may have inflated perceived effects, underscoring cautious use of this treatment in Ireland.